1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Passive Transdermal Drug Delivery 1.2.3 Active Transdermal Drug Delivery 1.3 Market by Application 1.3.1 Global Transmucosal Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Transmucosal Drug Delivery Market Perspective (2016-2027) 2.2 Transmucosal Drug Delivery Growth Trends by Regions 2.2.1 Transmucosal Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Transmucosal Drug Delivery Historic Market Share by Regions (2016-2021) 2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Regions (2022-2027) 2.3 Transmucosal Drug Delivery Industry Dynamic 2.3.1 Transmucosal Drug Delivery Market Trends 2.3.2 Transmucosal Drug Delivery Market Drivers 2.3.3 Transmucosal Drug Delivery Market Challenges 2.3.4 Transmucosal Drug Delivery Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Transmucosal Drug Delivery Players by Revenue 3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2016-2021) 3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2016-2021) 3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue 3.4 Global Transmucosal Drug Delivery Market Concentration Ratio 3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2020 3.5 Transmucosal Drug Delivery Key Players Head office and Area Served 3.6 Key Players Transmucosal Drug Delivery Product Solution and Service 3.7 Date of Enter into Transmucosal Drug Delivery Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Transmucosal Drug Delivery Breakdown Data by Type 4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2016-2021) 4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2022-2027) 5 Transmucosal Drug Delivery Breakdown Data by Application 5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2016-2021) 5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Transmucosal Drug Delivery Market Size (2016-2027) 6.2 North America Transmucosal Drug Delivery Market Size by Type 6.2.1 North America Transmucosal Drug Delivery Market Size by Type (2016-2021) 6.2.2 North America Transmucosal Drug Delivery Market Size by Type (2022-2027) 6.2.3 North America Transmucosal Drug Delivery Market Size by Type (2016-2027) 6.3 North America Transmucosal Drug Delivery Market Size by Application 6.3.1 North America Transmucosal Drug Delivery Market Size by Application (2016-2021) 6.3.2 North America Transmucosal Drug Delivery Market Size by Application (2022-2027) 6.3.3 North America Transmucosal Drug Delivery Market Size by Application (2016-2027) 6.4 North America Transmucosal Drug Delivery Market Size by Country 6.4.1 North America Transmucosal Drug Delivery Market Size by Country (2016-2021) 6.4.2 North America Transmucosal Drug Delivery Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Transmucosal Drug Delivery Market Size (2016-2027) 7.2 Europe Transmucosal Drug Delivery Market Size by Type 7.2.1 Europe Transmucosal Drug Delivery Market Size by Type (2016-2021) 7.2.2 Europe Transmucosal Drug Delivery Market Size by Type (2022-2027) 7.2.3 Europe Transmucosal Drug Delivery Market Size by Type (2016-2027) 7.3 Europe Transmucosal Drug Delivery Market Size by Application 7.3.1 Europe Transmucosal Drug Delivery Market Size by Application (2016-2021) 7.3.2 Europe Transmucosal Drug Delivery Market Size by Application (2022-2027) 7.3.3 Europe Transmucosal Drug Delivery Market Size by Application (2016-2027) 7.4 Europe Transmucosal Drug Delivery Market Size by Country 7.4.1 Europe Transmucosal Drug Delivery Market Size by Country (2016-2021) 7.4.2 Europe Transmucosal Drug Delivery Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Transmucosal Drug Delivery Market Size (2016-2027) 8.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type 8.2.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2027) 8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Application 8.3.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2027) 8.4 Asia-Pacific Transmucosal Drug Delivery Market Size by Region 8.4.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Transmucosal Drug Delivery Market Size (2016-2027) 9.2 Latin America Transmucosal Drug Delivery Market Size by Type 9.2.1 Latin America Transmucosal Drug Delivery Market Size by Type (2016-2021) 9.2.2 Latin America Transmucosal Drug Delivery Market Size by Type (2022-2027) 9.2.3 Latin America Transmucosal Drug Delivery Market Size by Type (2016-2027) 9.3 Latin America Transmucosal Drug Delivery Market Size by Application 9.3.1 Latin America Transmucosal Drug Delivery Market Size by Application (2016-2021) 9.3.2 Latin America Transmucosal Drug Delivery Market Size by Application (2022-2027) 9.3.3 Latin America Transmucosal Drug Delivery Market Size by Application (2016-2027) 9.4 Latin America Transmucosal Drug Delivery Market Size by Country 9.4.1 Latin America Transmucosal Drug Delivery Market Size by Country (2016-2021) 9.4.2 Latin America Transmucosal Drug Delivery Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Transmucosal Drug Delivery Market Size (2016-2027) 10.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type 10.2.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2027) 10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application 10.3.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2027) 10.4 Middle East & Africa Transmucosal Drug Delivery Market Size by Country 10.4.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 3M Pharmaceuticals 11.1.1 3M Pharmaceuticals Company Details 11.1.2 3M Pharmaceuticals Business Overview 11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction 11.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.1.5 3M Pharmaceuticals Recent Development 11.2 Acrux Limited 11.2.1 Acrux Limited Company Details 11.2.2 Acrux Limited Business Overview 11.2.3 Acrux Limited Transmucosal Drug Delivery Introduction 11.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.2.5 Acrux Limited Recent Development 11.3 ALZA Corporation 11.3.1 ALZA Corporation Company Details 11.3.2 ALZA Corporation Business Overview 11.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction 11.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.3.5 ALZA Corporation Recent Development 11.4 Antares Pharma, Inc. 11.4.1 Antares Pharma, Inc. Company Details 11.4.2 Antares Pharma, Inc. Business Overview 11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction 11.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.4.5 Antares Pharma, Inc. Recent Development 11.5 Apricus BioSciences, Inc 11.5.1 Apricus BioSciences, Inc Company Details 11.5.2 Apricus BioSciences, Inc Business Overview 11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction 11.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.5.5 Apricus BioSciences, Inc Recent Development 11.6 Aveva Drug Delivery Systems 11.6.1 Aveva Drug Delivery Systems Company Details 11.6.2 Aveva Drug Delivery Systems Business Overview 11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction 11.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.6.5 Aveva Drug Delivery Systems Recent Development 11.7 Corium International, Inc 11.7.1 Corium International, Inc Company Details 11.7.2 Corium International, Inc Business Overview 11.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction 11.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.7.5 Corium International, Inc Recent Development 11.8 DURECT Corporation 11.8.1 DURECT Corporation Company Details 11.8.2 DURECT Corporation Business Overview 11.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction 11.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.8.5 DURECT Corporation Recent Development 11.9 Generex Biotechnology Corporation 11.9.1 Generex Biotechnology Corporation Company Details 11.9.2 Generex Biotechnology Corporation Business Overview 11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction 11.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.9.5 Generex Biotechnology Corporation Recent Development 11.10 Inovio Pharmaceuticals, Inc. 11.10.1 Inovio Pharmaceuticals, Inc. Company Details 11.10.2 Inovio Pharmaceuticals, Inc. Business Overview 11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction 11.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.10.5 Inovio Pharmaceuticals, Inc. Recent Development 11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) 11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details 11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview 11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction 11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development 11.12 MedPharm LTD 11.12.1 MedPharm LTD Company Details 11.12.2 MedPharm LTD Business Overview 11.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction 11.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.12.5 MedPharm LTD Recent Development 11.13 Mylan, Inc. 11.13.1 Mylan, Inc. Company Details 11.13.2 Mylan, Inc. Business Overview 11.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction 11.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.13.5 Mylan, Inc. Recent Development 11.14 Nemaura Pharma Ltd 11.14.1 Nemaura Pharma Ltd Company Details 11.14.2 Nemaura Pharma Ltd Business Overview 11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction 11.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.14.5 Nemaura Pharma Ltd Recent Development 11.15 Nitto Denko Corporation 11.15.1 Nitto Denko Corporation Company Details 11.15.2 Nitto Denko Corporation Business Overview 11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction 11.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.15.5 Nitto Denko Corporation Recent Development 11.16 Noven Pharmaceuticals, Inc. 11.16.1 Noven Pharmaceuticals, Inc. Company Details 11.16.2 Noven Pharmaceuticals, Inc. Business Overview 11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction 11.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.16.5 Noven Pharmaceuticals, Inc. Recent Development 11.17 Pantec Biosolutions AG 11.17.1 Pantec Biosolutions AG Company Details 11.17.2 Pantec Biosolutions AG Business Overview 11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction 11.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.17.5 Pantec Biosolutions AG Recent Development 11.18 Tapemark 11.18.1 Tapemark Company Details 11.18.2 Tapemark Business Overview 11.18.3 Tapemark Transmucosal Drug Delivery Introduction 11.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.18.5 Tapemark Recent Development 11.18 tesa Labtec GmbH .1 tesa Labtec GmbH Company Details .2 tesa Labtec GmbH Business Overview .3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction .4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2016-2021) .5 tesa Labtec GmbH Recent Development 11.20 TEVA Pharmaceutical Industries Ltd. 11.20.1 TEVA Pharmaceutical Industries Ltd. Company Details 11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview 11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction 11.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development 11.21 Zosano Pharma 11.21.1 Zosano Pharma Company Details 11.21.2 Zosano Pharma Business Overview 11.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction 11.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2016-2021) 11.21.5 Zosano Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Passive Transdermal Drug Delivery Table 3. Key Players of Active Transdermal Drug Delivery Table 4. Global Transmucosal Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Transmucosal Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Transmucosal Drug Delivery Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Transmucosal Drug Delivery Market Share by Regions (2016-2021) Table 8. Global Transmucosal Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Transmucosal Drug Delivery Market Share by Regions (2022-2027) Table 10. Transmucosal Drug Delivery Market Trends Table 11. Transmucosal Drug Delivery Market Drivers Table 12. Transmucosal Drug Delivery Market Challenges Table 13. Transmucosal Drug Delivery Market Restraints Table 14. Global Transmucosal Drug Delivery Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Transmucosal Drug Delivery Market Share by Players (2016-2021) Table 16. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2020) Table 17. Ranking of Global Top Transmucosal Drug Delivery Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Transmucosal Drug Delivery Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Transmucosal Drug Delivery Product Solution and Service Table 21. Date of Enter into Transmucosal Drug Delivery Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million) Table 24. Global Transmucosal Drug Delivery Revenue Market Share by Type (2016-2021) Table 25. Global Transmucosal Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Transmucosal Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Transmucosal Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Transmucosal Drug Delivery Revenue Market Share by Application (2016-2021) Table 29. Global Transmucosal Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Transmucosal Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million) Table 32. North America Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million) Table 34. North America Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million) Table 61. 3M Pharmaceuticals Company Details Table 62. 3M Pharmaceuticals Business Overview Table 63. 3M Pharmaceuticals Transmucosal Drug Delivery Product Table 64. 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 65. 3M Pharmaceuticals Recent Development Table 66. Acrux Limited Company Details Table 67. Acrux Limited Business Overview Table 68. Acrux Limited Transmucosal Drug Delivery Product Table 69. Acrux Limited Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 70. Acrux Limited Recent Development Table 71. ALZA Corporation Company Details Table 72. ALZA Corporation Business Overview Table 73. ALZA Corporation Transmucosal Drug Delivery Product Table 74. ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 75. ALZA Corporation Recent Development Table 76. Antares Pharma, Inc. Company Details Table 77. Antares Pharma, Inc. Business Overview Table 78. Antares Pharma, Inc. Transmucosal Drug Delivery Product Table 79. Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 80. Antares Pharma, Inc. Recent Development Table 81. Apricus BioSciences, Inc Company Details Table 82. Apricus BioSciences, Inc Business Overview Table 83. Apricus BioSciences, Inc Transmucosal Drug Delivery Product Table 84. Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 85. Apricus BioSciences, Inc Recent Development Table 86. Aveva Drug Delivery Systems Company Details Table 87. Aveva Drug Delivery Systems Business Overview Table 88. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Table 89. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 90. Aveva Drug Delivery Systems Recent Development Table 91. Corium International, Inc Company Details Table 92. Corium International, Inc Business Overview Table 93. Corium International, Inc Transmucosal Drug Delivery Product Table 94. Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 95. Corium International, Inc Recent Development Table 96. DURECT Corporation Company Details Table 97. DURECT Corporation Business Overview Table 98. DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 99. DURECT Corporation Recent Development Table 100. Generex Biotechnology Corporation Company Details Table 101. Generex Biotechnology Corporation Business Overview Table 102. Generex Biotechnology Corporation Transmucosal Drug Delivery Product Table 103. Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 104. Generex Biotechnology Corporation Recent Development Table 105. Inovio Pharmaceuticals, Inc. Company Details Table 106. Inovio Pharmaceuticals, Inc. Business Overview Table 107. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Table 108. Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 109. Inovio Pharmaceuticals, Inc. Recent Development Table 110. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details Table 111. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview Table 112. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Table 113. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 114. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development Table 115. MedPharm LTD Company Details Table 116. MedPharm LTD Business Overview Table 117. MedPharm LTD Transmucosal Drug Delivery Product Table 118. MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 119. MedPharm LTD Recent Development Table 120. Mylan, Inc. Company Details Table 121. Mylan, Inc. Business Overview Table 122. Mylan, Inc. Transmucosal Drug Delivery Product Table 123. Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 124. Mylan, Inc. Recent Development Table 125. Nemaura Pharma Ltd Company Details Table 126. Nemaura Pharma Ltd Business Overview Table 127. Nemaura Pharma Ltd Transmucosal Drug Delivery Product Table 128. Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 129. Nemaura Pharma Ltd Recent Development Table 130. Nitto Denko Corporation Company Details Table 131. Nitto Denko Corporation Business Overview Table 132. Nitto Denko Corporation Transmucosal Drug Delivery Product Table 133. Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 134. Nitto Denko Corporation Recent Development Table 135. Noven Pharmaceuticals, Inc. Company Details Table 136. Noven Pharmaceuticals, Inc. Business Overview Table 137. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Table 138. Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 139. Noven Pharmaceuticals, Inc. Recent Development Table 140. Pantec Biosolutions AG Company Details Table 141. Pantec Biosolutions AG Business Overview Table 142. Pantec Biosolutions AG Transmucosal Drug Delivery Product Table 143. Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 144. Pantec Biosolutions AG Recent Development Table 145. Tapemark Company Details Table 146. Tapemark Business Overview Table 147. Tapemark Transmucosal Drug Delivery Product Table 148. Tapemark Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 149. Tapemark Recent Development Table 150. tesa Labtec GmbH Company Details Table 151. tesa Labtec GmbH Business Overview Table 152. tesa Labtec GmbH Transmucosal Drug Delivery Product Table 153. tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 154. tesa Labtec GmbH Recent Development Table 155. TEVA Pharmaceutical Industries Ltd. Company Details Table 156. TEVA Pharmaceutical Industries Ltd. Business Overview Table 157. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Table 158. TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 159. TEVA Pharmaceutical Industries Ltd. Recent Development Table 160. Zosano Pharma Company Details Table 161. Zosano Pharma Business Overview Table 162. Zosano Pharma Transmucosal Drug Delivery Product Table 163. Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million) Table 164. Zosano Pharma Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Transmucosal Drug Delivery Market Share by Type: 2020 VS 2027 Figure 2. Passive Transdermal Drug Delivery Features Figure 3. Active Transdermal Drug Delivery Features Figure 4. Global Transmucosal Drug Delivery Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Others Case Studies Figure 8. Transmucosal Drug Delivery Report Years Considered Figure 9. Global Transmucosal Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Transmucosal Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Transmucosal Drug Delivery Market Share by Regions: 2020 VS 2027 Figure 12. Global Transmucosal Drug Delivery Market Share by Regions (2022-2027) Figure 13. Global Transmucosal Drug Delivery Market Share by Players in 2020 Figure 14. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2020 Figure 16. Global Transmucosal Drug Delivery Revenue Market Share by Type (2016-2021) Figure 17. Global Transmucosal Drug Delivery Revenue Market Share by Type (2022-2027) Figure 18. North America Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Transmucosal Drug Delivery Market Share by Type (2016-2027) Figure 20. North America Transmucosal Drug Delivery Market Share by Application (2016-2027) Figure 21. North America Transmucosal Drug Delivery Market Share by Country (2016-2027) Figure 22. United States Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Transmucosal Drug Delivery Market Share by Type (2016-2027) Figure 26. Europe Transmucosal Drug Delivery Market Share by Application (2016-2027) Figure 27. Europe Transmucosal Drug Delivery Market Share by Country (2016-2027) Figure 28. Germany Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Transmucosal Drug Delivery Market Share by Type (2016-2027) Figure 36. Asia-Pacific Transmucosal Drug Delivery Market Share by Application (2016-2027) Figure 37. Asia-Pacific Transmucosal Drug Delivery Market Share by Region (2016-2027) Figure 38. China Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Transmucosal Drug Delivery Market Share by Type (2016-2027) Figure 46. Latin America Transmucosal Drug Delivery Market Share by Application (2016-2027) Figure 47. Latin America Transmucosal Drug Delivery Market Share by Country (2016-2027) Figure 48. Mexico Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Transmucosal Drug Delivery Market Share by Type (2016-2027) Figure 52. Middle East & Africa Transmucosal Drug Delivery Market Share by Application (2016-2027) Figure 53. Middle East & Africa Transmucosal Drug Delivery Market Share by Country (2016-2027) Figure 54. Turkey Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. 3M Pharmaceuticals Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 58. Acrux Limited Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 59. ALZA Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 60. Antares Pharma, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 61. Apricus BioSciences, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 62. Aveva Drug Delivery Systems Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 63. Corium International, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 64. DURECT Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 65. Generex Biotechnology Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 66. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 67. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 68. MedPharm LTD Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 69. Mylan, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 70. Nemaura Pharma Ltd Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 71. Nitto Denko Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 72. Noven Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 73. Pantec Biosolutions AG Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 74. Tapemark Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 75. tesa Labtec GmbH Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 76. TEVA Pharmaceutical Industries Ltd. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 77. Zosano Pharma Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

3M Pharmaceuticals Acrux Limited ALZA Corporation Antares Pharma, Inc. Apricus BioSciences, Inc Aveva Drug Delivery Systems Corium International, Inc DURECT Corporation Generex Biotechnology Corporation Inovio Pharmaceuticals, Inc. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) MedPharm LTD Mylan, Inc. Nemaura Pharma Ltd Nitto Denko Corporation Noven Pharmaceuticals, Inc. Pantec Biosolutions AG Tapemark tesa Labtec GmbH TEVA Pharmaceutical Industries Ltd. Zosano Pharma